Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
DF Dent & Co. Inc. Buys 61,080 Shares of The Descartes Systems Group Inc. (NASDAQ:DSGX)
DF Dent & Co. Inc. increased its stake in shares of The Descartes Systems Group Inc. (NASDAQ:DSGX – Free Report)...
Glen Eagle Advisors LLC Makes New Investment in Innovator Equity Managed Floor ETF (NYSEARCA:SFLR)
Glen Eagle Advisors LLC acquired a new stake in Innovator Equity Managed Floor ETF (NYSEARCA:SFLR – Free Report) during the...
DF Dent & Co. Inc. Has $87.85 Million Stock Holdings in Repligen Co. (NASDAQ:RGEN)
DF Dent & Co. Inc. increased its holdings in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 31.0% in...
Brookfield Corp ON Purchases 547,253 Shares of Golar LNG Limited (NASDAQ:GLNG)
Brookfield Corp ON grew its position in Golar LNG Limited (NASDAQ:GLNG – Free Report) by 180.8% during the third quarter,...
Brookfield Corp ON Boosts Stake in Sempra (NYSE:SRE)
Brookfield Corp ON raised its position in Sempra (NYSE:SRE – Free Report) by 7.8% during the third quarter, according to...
Atlantica Sustainable Infrastructure plc (NASDAQ:AY) Stock Holdings Decreased by Brookfield Corp ON
Brookfield Corp ON reduced its position in Atlantica Sustainable Infrastructure plc (NASDAQ:AY – Free Report) by 32.1% in the 3rd...